Cargando…
Identification of a novel CHEK2 variant and assessment of its contribution to the risk of breast cancer in French Canadian women
BACKGROUND: BRCA1 and BRCA2 account for the majority of the known familial breast cancer risk, however, the impact of other cancer susceptibility genes largely remains to be elucidated. Checkpoint Kinase 2 (CHEK2) is an important signal transducer of cellular responses to DNA damage, whose defects h...
Autores principales: | Novak, David J, Chen, Long Qi, Ghadirian, Parviz, Hamel, Nancy, Zhang, Phil, Rossiny, Vanessa, Cardinal, Guy, Robidoux, André, Tonin, Patricia N, Rousseau, Francois, Narod, Steven A, Foulkes, William D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2532692/ https://www.ncbi.nlm.nih.gov/pubmed/18706089 http://dx.doi.org/10.1186/1471-2407-8-239 |
Ejemplares similares
-
Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women
por: Foulkes, William D, et al.
Publicado: (2007) -
Weight History, Smoking, Physical Activity and Breast Cancer Risk among French-Canadian Women Non-Carriers of More Frequent BRCA1/2 Mutations
por: Bissonauth, Vishnee, et al.
Publicado: (2009) -
Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families
por: Oros, Kathleen K, et al.
Publicado: (2006) -
Germline TP53 mutational spectrum in French Canadians with breast cancer
por: Arcand, Suzanna L, et al.
Publicado: (2015) -
RAD51C germline mutations in breast and ovarian cancer patients
por: Akbari, Mohammad R, et al.
Publicado: (2010)